<?xml version="1.0" encoding="UTF-8"?>
<p>The BTA scaffold possesses a wide spectrum of biological activities such as anti-inflammatory
 <xref rid="CIT0006" ref-type="bibr">
  <sup>6</sup>
 </xref>, fungicidal
 <xref rid="CIT0007" ref-type="bibr">
  <sup>7</sup>
 </xref>, anti-diabetic
 <xref rid="CIT0008" ref-type="bibr">
  <sup>8</sup>
 </xref>, analgesic
 <xref rid="CIT0009" ref-type="bibr">
  <sup>9</sup>
 </xref>, anti-microbial
 <xref rid="CIT0010" ref-type="bibr">
  <sup>10</sup>
 </xref>, antitumor
 <xref rid="CIT0011" ref-type="bibr">
  <sup>11</sup>
 </xref>, antileishmanial
 <xref rid="CIT0012" ref-type="bibr">
  <sup>12</sup>
 </xref>, antheltmintic
 <xref rid="CIT0013" ref-type="bibr">
  <sup>13</sup>
 </xref>, antirheumatic
 <xref rid="CIT0014" ref-type="bibr">
  <sup>14</sup>
 </xref> and CNS depressant
 <xref rid="CIT0015" ref-type="bibr">
  <sup>15</sup>
 </xref> etc. BTA derivatives exhibit remarkable and prevalent biological and pharmacological activities against different types of tumours and cancer cell lines such as HeLa (human cervical cancer cell line), SW480 (human colon adenocarcinoma cell line), HepG2 (human liver carcinoma cells)
 <xref rid="CIT0016" ref-type="bibr">
  <sup>16</sup>
 </xref>, mammary and ovarian tumour cell lines
 <xref rid="CIT0017" ref-type="bibr">
  <sup>17</sup>
 </xref>, colon, nonsmall-cell lung and breast subpanels cell lines
 <xref rid="CIT0018" ref-type="bibr">
  <sup>18</sup>
 </xref>, and HCC (hepatocellular carcinoma)
 <xref rid="CIT0019" ref-type="bibr">
  <sup>19</sup>
 </xref> etc.
</p>
